Prostate carcinoma and the Lambert-Eaton myasthenic syndrome

Journal of Urology

Volumn 169, Issue 1, 2003, Pages 278-279

  Delahunt, B ^a   Abernethy, D A ^a   Johnson, C A ^a   Nacey, J N ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Carcinoma, neuroendocrine; Lambert Eaton myasthenic syndrome; Prostatic neoplasms

Indexed keywords

3,4 DIAMINOPYRIDINE; ANTIANDROGEN; GOSERELIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0037213524     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64091-8     Document Type: Article

References (3)

1. Clouston, P. D., Saper, C. S., Arbizu, T., Johnston, I., Lang, B., Newsom-Davis, J. et al: Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer and the Lambert-Eaton myasthenic syndrome. Neurology, 42: 1944, 1992
2. Tetu, B., Ro, J. Y., Ayala, A. G., Ordonez, N. G., Logothetis, C. J. and von Eschenbach, A. C.: Small cell carcinoma of the prostate with myasthenic (Eaton-Lambert) syndrome. Urology, 33: 148, 1989
3. Agarawl, S. K., Birch, B. R. and Abercrombie, G. F.: Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association. Scand J Urol Nephrol, 29: 351, 1995